Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 4
2005 7
2006 5
2007 2
2008 7
2009 2
2010 7
2011 10
2012 12
2013 4
2014 11
2015 14
2016 21
2017 26
2018 22
2019 7
2020 7
2021 16
2022 17
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing tumour necrosis factor-alfa inhibitors in juvenile idiopathic arthritis.
Florax AA, Doeleman MJH, de Roock S, van der Linden N, Schatorjé E, Currie G, Marshall DA, IJzerman MJ, Yeung RSM, Benseler SM, Vastert SJ, Wulffraat NM, Swart JF, Kip MMA; for UCAN-CAN DU and UCAN CURE consortia. Florax AA, et al. Among authors: ijzerman mj. Rheumatology (Oxford). 2023 Dec 20:kead688. doi: 10.1093/rheumatology/kead688. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38123516
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia.
Vu M, Degeling K, Thompson ER, Blombery P, Westerman D, IJzerman MJ. Vu M, et al. Among authors: ijzerman mj. Appl Health Econ Health Policy. 2024 Jan;22(1):107-122. doi: 10.1007/s40258-023-00826-4. Epub 2023 Aug 22. Appl Health Econ Health Policy. 2024. PMID: 37608228 Free PMC article.
Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?
van Til JA, Kip MMA, Schatorjé EJH, Currie G, Twilt M, Benseler SM, Swart JF, Vastert SJ, Wulffraat N, Yeung RSM, Groothuis-Oudshoorn CGMK, Warta S, Marshall DA, IJzerman MJ; UCAN CAN-DU, UCAN CURE consortia. van Til JA, et al. Among authors: ijzerman mj. Pediatr Rheumatol Online J. 2023 Jul 11;21(1):69. doi: 10.1186/s12969-023-00845-4. Pediatr Rheumatol Online J. 2023. PMID: 37434157 Free PMC article.
What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey.
Currie GR, Groothuis-Oudshoorn CGM, Twilt M, Kip MMA, IJzerman MJ, Benseler SM, Swart JF, Vastert SJ, Wulffraat NM, Yeung R, Marshall DA. Currie GR, et al. Among authors: ijzerman mj. Clin Rheumatol. 2023 Aug;42(8):2173-2180. doi: 10.1007/s10067-023-06616-6. Epub 2023 May 19. Clin Rheumatol. 2023. PMID: 37202606
196 results